Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.56
-0.10 (-3.76%)
At close: Aug 15, 2025, 3:59 PM
2.57
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

Orchestra BioMed Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-19.36M -18.75M -16.16M -15.43M -15.98M -13.46M -12.82M -13.32M -12.05M -10.94M -9.75M -685.79K -7.85M -5.73M -88.01K -5.26M -6.16M -3.54M
Depreciation & Amortization
81K 83K 84K 76K 74K 74K 72K 71K 73K 71K 70K 54K 50K 48K 48K 46K 44K 43K
Stock-Based Compensation
3.25M 2.96M 2.9M 2.36M 2.76M 2.59M 919K 3.51M 1.71M 1.49M 863K 2.22M 257K 70K 39K 67K 135K 61K
Other Working Capital
n/a -1.03M -1.46M -6M 3.04M -1.9M -95K 487K -728K -1.02M 40K 241.93K -229K -716K 63.21K -20K -62K 102K
Other Non-Cash Items
147K 81K 994K 523K -132K -479K 2.05M -867K -867K -865K 1.85M -127.62K 173K 187K -4.03K 388K 1.68M -2.33M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -1.08M -293K 31K 280K -1.87M -2.28M -33K 365K n/a n/a n/a n/a
Change in Working Capital
358K -990K -1.36M -1.24M 3.07M -1.83M -116K 613K 612K -4.42M 94K 241.93K -565K -265K 63.21K -72K -113K 179K
Operating Cash Flow
-15.53M -16.62M -13.54M -13.7M -10.21M -13.11M -10.97M -10.28M -10.49M -14.38M -8.74M -571.49K -7.96M -5.32M -28.84K -4.83M -4.41M -5.59M
Capital Expenditures
-34K -112K -106K -68K -107K -8K 3K -19K -27K -35K -54K -224K -266K -47K -124K -53K n/a -97K
Cash Acquisitions
n/a n/a -602K n/a n/a n/a -33.15M -12.97M -64.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a -2.9M -20.27M -9.99M -18.65M -23.74M -3.96M -38.52M -56.05M -43.49M -63.32M n/a -208K n/a n/a n/a n/a n/a
Sales Maturities Of Investments
16.39M 16.01M 17.23M 10.61M 29.18M 29.61M 37.11M 51.49M 64.2M n/a n/a 92.59M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 33.15M 12.97M 64.2M -43.49M -63.32M 224K -208K n/a -213K 6.33M 6.33M 840K
Investing Cash Flow
16.36M 13M -3.75M 557K 10.42M 5.86M 33.15M 12.95M 8.12M -43.53M -63.38M 92.59M -474K -47K -337K 6.28M 6.33M 743K
Debt Repayment
n/a n/a 15M n/a n/a n/a -10.85M n/a n/a n/a n/a n/a 4.55M -1M -1M -1M -1M -1M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -109.83M -92.59M n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-428K -387K -1.1M n/a n/a n/a n/a n/a 86K 56.82M -5.09M -2.5M -1.03M -1.51M 7K n/a n/a n/a
Financial Cash Flow
-428K -296K 13.95M 15.04M 171K 18K -10.7M 4K 86K 56.82M -5.09M -92.59M 86.08M 24.76M -993K -1M -1M -1M
Net Cash Flow
401K -3.91M -3.34M 1.89M 389K -7.24M 11.48M 2.67M -2.29M -1.09M -77.21M -571.49K 77.64M 19.39M -28.84K 448K 925K -5.84M
Free Cash Flow
-15.56M -16.73M -13.64M -13.77M -10.31M -13.12M -10.97M -10.3M -10.52M -14.42M -8.8M -795.49K -8.23M -5.37M -152.84K -4.88M -4.41M -5.68M